11 March 2016 - Deborah Wilkes
Archived
"For the majority of OTC companies, excellence in execution still represents the single most important growth opportunity," according to Boehringer Ingelheim Consumer Health Care's Oliver Freichel.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.